SISTEMA INTEGRAL DE INFORMACIÓN ACADÉMICA - PÚBLICO

Fragoso J.M.
(Autor externo)

Obras con ISBN:0
Documentos en revistas:77
Colaboraciones en Tesis:0
Patentes:0
Obras con ISBN:No hay obras de este autor.
Documentos en revistas:
1.- High-Density Lipoproteins (HDLs) contribute to limiting acute tissue damage: proof of concept in a model of mercury-induced nephrotoxicity (2026)
 
2.- The Functional OAS1 rs10774671A>G Variant Is Associated with COVID-19 Susceptibility in Mexican Patients (2026)
 
3.- Genetic association of proinflammatory cytokines in the pathogenesis of frailty syndrome: an application of ordinal logistic regression model (2025)
 
4.- The fatal contribution of serine protease-related genetic variants to COVID-19 outcomes (2024)
 
5.- ACE and ACE2 Gene Variants Are Associated With Severe Outcomes of COVID-19 in Men (2022)
 
6.- The rs8176740 T/A and rs512770 T/C Genetic Variants of the ABO Gene Increased the Risk of COVID-19, as well as the Plasma Concentration Platelets (2022)
 
7.- FOXA3 Polymorphisms Are Associated with Metabolic Parameters in Individuals with Subclinical Atherosclerosis and Healthy Controls?The GEA Mexican Study (2022)
 
8.- CASP1 Gene Polymorphisms and BAT1-NFKBIL-LTA-CASP1 Gene?Gene Interactions Are Associated with Restenosis after Coronary Stenting (2022)
 
9.- The rs4783961 and rs708272 genetic variants of the CETP gene are associated with coronary artery disease, but not with restenosis after coronary stenting (2022)
 
10.- TNFSF4 is a risk factor for rheumatoid arthritis but not for primary Sjögren's syndrome in the Mexican population (2022)
 
11.- Association of the Transmembrane Serine Protease-2 (TMPRSS2) Polymorphisms with COVID-19 (2022)
 
12.- Native Low-Density Lipoproteins Act in Synergy with Lipopolysaccharide to Alter the Balance of Human Monocyte Subsets and Their Ability to Produce IL-1 Beta, CCR2, and CX3CR1 In Vitro and In Vivo: Implications in Atherogenesis (2021)
 
13.- TNFSF4 is a risk factor to systemic lupus erythematosus in a Latin American population (2021)
 
14.- Interferon regulatory factor 5 (Irf5) gene haplotypes are associated with premature coronary artery disease association of the irf5 polymorphisms with cardiometabolic parameters the genetics of atherosclerotic disease (gea) Mexican study (2021)
 
15.- Dipeptidylpeptidase-4 levels and DPP4 gene polymorphisms in patients with COVID-19. Association with disease and with severity (2021)
 
16.- Trp fluorescence redshift during hdl apolipoprotein denaturation is increased in patients with coronary syndrome in acute phase: A new assay to evaluate hdl stability (2021)
 
17.- The rs508487, rs236911 and rs236918 genetic variants of the proprotein convertase subtilisin?kexin type 7 (Pcsk7) gene are associated with acute coronary syndrome and with plasma concentrations of hdl-cholesterol and triglycerides (2021)
 
18.- Two genetic variants in the promoter region of the CCL5 gene are associated with the risk of acute coronary syndrome and with a lower plasma CCL5 concentration (2020)
 
19.- Il-37 gene and cholesterol metabolism: Association of polymorphisms with the presence of hypercholesterolemia and cardiovascular risk factors. the gea mexican study (2020)
 
20.- The c.*52 A/G and c.*773 A/G genetic variants in the UTR'3 of the LDLR gene are associated with the risk of acute coronary syndrome and lower plasma HDL-cholesterol concentration (2020)
 
21.- Association of BLK and BANK1 Polymorphisms and Interactions With Rheumatoid Arthritis in a Latin-American Population (2020)
 
22.- THE BRANCHED-CHAIN AMINO ACID TRANSAMINASE 1 -23C/G POLYMORPHISM CONFERS PROTECTION AGAINST ACUTE CORONARY SYNDROME (2020)
 
23.- Bone morphogenetic protein-2 and osteopontin gene expression in epicardial adipose tissue from patients with coronary artery disease is associated with the presence of calcified atherosclerotic plaques (2020)
 
24.- Microencapsulated Pomegranate Modifies the Composition and Function of High-Density Lipoproteins (HDL) in New Zealand Rabbits (2020)
 
25.- M2 macrophage immunotherapy abolishes glucose intolerance by increasing IL-10 expression and AKT activation (2020)
 
26.- The Ser290Asn and Thr715Pro Polymorphisms of the SELP Gene Are Associated with A Lower Risk of Developing Acute Coronary Syndrome and Low Soluble P-Selectin Levels in A Mexican Population ? (2020)
 
27.- BLK and BANK1 polymorphisms and interactions are associated in Mexican patients with systemic lupus erythematosus (2019)
 
28.- Interleukin 27 polymorphisms, their association with insulin resistance and their contribution to subclinical atherosclerosis. The GEA Mexican study (2019)
 
29.- Atorvastatin and Fenofibrate Exert Opposite Effects on the Vascularization and Characteristics of Visceral Adipose Tissue in New Zealand White Rabbits (2019)
 
30.- Atorvastatin and Fenofibrate Increase the Content of Unsaturated Acyl Chains in HDL and Modify In Vivo Kinetics of HDL-Cholesteryl Esters in New Zealand White Rabbits (2019)
 
31.- Microencapsulated pomegranate reverts high-density lipoprotein (HDL)-induced endothelial dysfunction and reduces postprandial triglyceridemia in women with acute coronary syndrome (2019)
 
32.- The rs10455872-g allele of the lpa gene is associated with high lipoprotein(A) levels and increased aortic valve calcium in a mexican adult population (2019)
 
33.- SREBF1c and SREBF2 gene polymorphisms are associated with acute coronary syndrome and blood lipid levels in Mexican population (2019)
 
34.- Interleukin 10 gene polymorphisms and frailty syndrome in elderly Mexican people: (Sadem study) (2019)
 
35.- The rs2066808 Polymorphism Located Near the IL-23A Gene Is Associated with Premature Coronary Artery Disease in Mexican Population (GEA Study) (2019)
 
36.- miR-196a2 (rs11614913) polymorphism is associated with coronary artery disease, but not with in-stent coronary restenosis (2019)
 
37.- The -44 C/G (rs1800972) polymorphism of the ß-defensin 1 is associated with increased risk of developing type 2 diabetes mellitus (2019)
 
38.- The rs1805193, rs5361, and rs5355 single nucleotide polymorphisms in the E-selectin gene (SEL-E) are associated with subclinical atherosclerosis: The Genetics of Atherosclerotic Disease (GEA) Mexican study (2019)
 
39.- MRE11A polymorphisms are associated with subclinical atherosclerosis and cardiovascular risk factors. A case-control study of the GEA Mexican project (2019)
 
40.- Raet1e Polymorphisms Are Associated with Increased Risk of Developing Premature Coronary Artery Disease and with Some Cardiometabolic Parameters: The GEA Mexican Study (2018)
 
41.- Tumor necrosis factor (TNF) and TNFR1 polymorphisms are not risk factors for rheumatoid arthritis in a Mexican population (2018)
 
42.- The VEGFA -1154G/A polymorphism is associated with reduced risk of rheumatoid arthritis but not with systemic lupus erythematosus in Mexican women (2018)
 
43.- The IL-10-1082 (rs1800896) G allele is associated with a decreased risk of developing premature coronary artery disease and some IL-10 polymorphisms were associated with clinical and metabolic parameters. The GEA study (2018)
 
44.- Characterization of immortalized human dermal microvascular endothelial cells (HMEC-1) for the study of HDL functionality (2018)
 
45.- CETP and LCAT Gene Polymorphisms Are Associated with High-Density Lipoprotein Subclasses and Acute Coronary Syndrome (2018)
 
46.- Hyperuricemia is Associated with Increased Apo AI Fractional Catabolic Rates and Dysfunctional HDL in New Zealand Rabbits (2017)
 
47.- Association of the I148M/PNPLA3 (rs738409) polymorphism with premature coronary artery disease, fatty liver, and insulin resistance in type 2 diabetic patients and healthy controls. The GEA study (2017)
 
48.- IL-15 polymorphisms are associated with subclinical atherosclerosis and cardiovascular risk factors. The Genetics of Atherosclerosis Disease (GEA) Mexican Study (2017)
 
49.- Differential expression of osteopontin, and osteoprotegerin mRNA in epicardial adipose tissue between patients with severe coronary artery disease and aortic valvular stenosis: Association with HDL subclasses (2017)
 
50.- The NLRP3 and CASP1 gene polymorphisms are associated with developing of acute coronary syndrome: a case-control study (2017)
 
51.- The T > A (rs11646213) gene polymorphism of cadherin-13 (CDH13) gene is associated with decreased risk of developing hypertension in Mexican population (2017)
 
52.- HDL-sphingomyelin reduction after weight loss by an energy-restricted diet is associated with the improvement of lipid profile, blood pressure, and decrease of insulin resistance in overweight/obese patients (2016)
 
53.- The T29C (rs1800470) polymorphism of the transforming growth factor-ß1 (TGF-ß1) gene is associated with restenosis after coronary stenting in Mexican patients (2015)
 
54.- The variant rs8048002 T > C in intron 3 of the MHC2TA gene is associated with risk of developing acute coronary syndrome (2015)
 
55.- Interleukin-17A gene haplotypes are associated with risk of premature coronary artery disease in Mexican patients from the genetics of atherosclerotic disease (GEA) study (2015)
 
56.- The C4280A (rs5705) gene polymorphism of the renin (REN) gene is associated with risk of developing coronary artery disease, but not with restenosis after coronary stenting (2015)
 
57.- Atorvastatin and fenofibrate combination induces the predominance of the large HDL subclasses and increased apo AI fractional catabolic rates in New Zealand white rabbits with exogenous hypercholesterolemia (2015)
 
58.- Monocyte chemoattractant protein-1 gene (MCP-1) polymorphisms are associated with risk of premature coronary artery disease in Mexican patients from the Genetics of Atherosclerotic Disease (GEA) study (2015)
 
59.- The interleukin-1ß-511 T>C (rs16944) gene polymorphism is associated with risk of developing silent myocardial ischemia in diabetic patients (2015)
 
60.- C3435T polymorphism of the ABCB1 gene is associated with poor clopidogrel responsiveness in a Mexican population undergoing percutaneous coronary intervention (2015)
 
61.- Low concentrations of phospholipids and plasma HDL cholesterol subclasses in asymptomatic subjects with high coronary calcium scores (2015)
 
62.- El factor de necrosis tumoral a(TNF-a) en las enfermedades autoinmunes (EA): Biología molecular y genética (2014)
 
63.- Single nucleotide polymorphisms (SNPs): Functional implications of regulatory-SNP (rSNP) and structural RNA (srSNPs) in complex diseases [Polimorfismos de un solo nucleótido (SNP): Implicaciones funcionales de los SNP reguladores (rSNP) y d (2013)
 
64.- Toll-like receptor 4 gene polymorphisms and acute coronary syndrome: No association in a Mexican population [No existe asociación entre los polimorfismos del receptor tipo toll-4 y el syndrome coronario agudo] (2013)
 
65.- The MHC2TA gene polymorphisms are not associated with restenosis after coronary stenting in Mexican patients [Los polimorfismos del gen MHC2TA no se asocian con la reestenosis después del implante de stent coronario en pacientes mexicanos] (2012)
 
66.- Acute coronary syndrome. Physiopathology and genetics [Síndrome coronario agudo. Fisiopatología y genética] (2011)
 
67.- Genetic and genomic studies in the hypertension: An actualization [Genética y genómica de la hipertensión arterial: Una actualización] (2011)
 
68.- The risk of developing cervical cancer in Mexican women is associated to CYP1A1 MspI polymorphism (2007)
 
69.- MHC class II genes in Mexican patients with idiopathic dilated cardiomyopathy (2007)
 
70.- ß1-adrenergic receptor gene polymorphisms in Mexican patients with idiopathic dilated cardiomyopathy (2006)
 
71.- Distribution of paraoxonase PON1 gene polymorphisms in Mexican populations. Its role in the lipid profile (2006)
 
72.- ß1 adrenergic receptor polymorphisms Arg389Gly and Ser49Gly in the Amerindian and Mestizo populations of Mexico (2005)
 
73.- Cytochrome P4501A1 polymorphisms in the Amerindian and Mestizo populations of Mexico (2005)
 
74.- Matrix ?-carboxyglutamic acid protein (MGP) G-7A and T-138C gene polymorphisms in Indian (Mayo and Teenek) and mestizo populations from Mexico (2005)
 
75.- Association study of LMP gene polymorphisms in Mexican patients with spondyloarthritis (2004)
 
76.- Tumor necrosis factor-alpha promoter polymorphisms in Mexican patients with rheumatic heart disease (2003)
 
77.- Angiotensin-Converting Enzyme Gene (ACE) Insertion/Deletion Polymorphism in Mexican Populations (2003)
 
Colaboraciones en Tesis:No hay tesis de este autor.
Patentes:No hay patentes de este autor.